Sofinnova Investments as of Dec. 31, 2024
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 60 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 17.9 | $245M | 1.6M | 158.30 | |
| Vera Therapeutics Cl A (VERA) | 8.6 | $118M | 2.8M | 42.29 | |
| Gilead Sciences (GILD) | 5.2 | $72M | 774k | 92.37 | |
| Abbvie (ABBV) | 4.7 | $64M | 359k | 177.70 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.5 | $62M | 504k | 123.15 | |
| Sarepta Therapeutics (SRPT) | 3.8 | $52M | 429k | 121.59 | |
| Axsome Therapeutics Call Option (AXSM) | 3.6 | $50M | 592k | 84.61 | |
| Arrivent Biopharma (AVBP) | 3.3 | $45M | 1.7M | 26.64 | |
| AstraZeneca Sponsored Adr | 3.1 | $43M | 651k | 65.52 | |
| Stryker Corporation (SYK) | 3.0 | $42M | 116k | 360.05 | |
| Replimune Group (REPL) | 2.8 | $38M | 3.1M | 12.11 | |
| Incyte Corporation (INCY) | 2.6 | $36M | 524k | 69.07 | |
| Rapport Therapeutics (RAPP) | 2.6 | $35M | 2.0M | 17.74 | |
| Soleno Therapeutics (SLNO) | 2.5 | $34M | 757k | 44.95 | |
| Boston Scientific Corporation (BSX) | 2.3 | $31M | 347k | 89.32 | |
| Ideaya Biosciences (IDYA) | 2.0 | $28M | 1.1M | 25.70 | |
| Alnylam Pharmaceuticals (ALNY) | 1.9 | $26M | 110k | 235.31 | |
| Alkermes SHS (ALKS) | 1.9 | $26M | 894k | 28.76 | |
| Dyne Therapeutics (DYN) | 1.8 | $25M | 1.1M | 23.56 | |
| Dex (DXCM) | 1.6 | $23M | 290k | 77.77 | |
| Rhythm Pharmaceuticals (RYTM) | 1.6 | $22M | 397k | 55.98 | |
| Globus Med Cl A (GMED) | 1.5 | $20M | 245k | 82.71 | |
| Intuitive Surgical (ISRG) | 1.4 | $20M | 38k | 521.96 | |
| Insmed Com Par $.01 (INSM) | 1.3 | $18M | 256k | 69.04 | |
| Y Mabs Therapeutics | 1.3 | $17M | 2.2M | 7.83 | |
| Savara (SVRA) | 1.2 | $17M | 5.5M | 3.07 | |
| Janux Therapeutics (JANX) | 1.0 | $14M | 253k | 53.54 | |
| Bioage Labs (BIOA) | 1.0 | $13M | 2.3M | 5.79 | |
| Inozyme Pharma (INZY) | 0.9 | $12M | 4.3M | 2.77 | |
| Eli Lilly & Co. (LLY) | 0.8 | $11M | 14k | 772.00 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $11M | 403k | 26.70 | |
| Pharvaris N V (PHVS) | 0.8 | $11M | 561k | 19.17 | |
| Aerovate Therapeutics (AVTE) | 0.7 | $10M | 3.8M | 2.65 | |
| Inari Medical Ord | 0.7 | $9.2M | 181k | 51.05 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $8.7M | 659k | 13.22 | |
| Inhibrx Biosciences (INBX) | 0.6 | $8.1M | 527k | 15.40 | |
| Immunome (IMNM) | 0.6 | $7.9M | 747k | 10.62 | |
| Cogent Biosciences (COGT) | 0.5 | $6.4M | 823k | 7.80 | |
| Achieve Life Sciences (ACHV) | 0.3 | $4.6M | 1.3M | 3.52 | |
| Erasca (ERAS) | 0.3 | $4.5M | 1.8M | 2.51 | |
| Establishment Labs Holdings Ord (ESTA) | 0.3 | $4.4M | 95k | 46.07 | |
| Avantor (AVTR) | 0.3 | $4.2M | 200k | 21.07 | |
| Edwards Lifesciences (EW) | 0.2 | $3.0M | 40k | 74.03 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $2.9M | 52k | 56.19 | |
| Immatics SHS (IMTX) | 0.2 | $2.4M | 343k | 7.11 | |
| Danaher Corporation (DHR) | 0.2 | $2.3M | 10k | 229.55 | |
| Nextcure | 0.2 | $2.1M | 2.7M | 0.77 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $1.8M | 133k | 13.24 | |
| Keros Therapeutics (KROS) | 0.1 | $1.5M | 95k | 15.83 | |
| Bolt Biotherapeutics | 0.1 | $1.5M | 2.8M | 0.54 | |
| Disc Medicine (IRON) | 0.1 | $1.4M | 23k | 63.40 | |
| Becton, Dickinson and (BDX) | 0.1 | $1.1M | 5.0k | 226.87 | |
| Vir Biotechnology (VIR) | 0.1 | $838k | 114k | 7.34 | |
| ICU Medical, Incorporated (ICUI) | 0.1 | $776k | 5.0k | 155.17 | |
| Enliven Therapeutics (ELVN) | 0.1 | $766k | 34k | 22.50 | |
| Ikena Oncology (IKNA) | 0.0 | $628k | 383k | 1.64 | |
| Travere Therapeutics (TVTX) | 0.0 | $568k | 33k | 17.42 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $567k | 21k | 27.12 | |
| Pulmonx Corp (LUNG) | 0.0 | $416k | 61k | 6.79 | |
| Avidity Biosciences Ord (RNA) | 0.0 | $401k | 14k | 29.08 |
